GLOSSARY

Glucose Counter-Regulation is coordinated defense limiting falling glucose.

Blood glucose reflects food entry, endogenous production and tissue removal under coordinated insulin, glucagon and other neural and hormonal signals. A transient meal response is not the same as persistent impaired glucose tolerance; sampling method and timing matter. Measuring glucose is not directly measuring all energy available to muscle. Glycogen, exercise intensity and other fuels also enter sports interpretation, so one curve cannot by itself rate every meal or establish a diagnosis.

Insulin is secreted by pancreatic beta cells and coordinates nutrient use and storage rather than simply being a fat-making hormone. Important effects include muscle and adipose glucose uptake, suppression of hepatic glucose production and regulation of lipolysis. Not every cell needs insulin for glucose entry. Postmeal concentrations vary with meal composition, tissue sensitivity and clearance, so one insulin excursion cannot determine overall dietary quality or an athlete's nutritional needs.

Glucagon is mainly secreted by alpha cells and supports glucose availability, prominently through the liver. Its response is not simply the inverse of insulin: amino acids and meal type matter, and both can rise after protein. Direct skeletal-muscle effects should not be assumed equivalent to hepatic effects. Their ratio is context-dependent rather than a food-quality score, and changes need secretion, clearance and tissue actions considered together.

For practical use, record meal and training timing, sleep and hunger alongside actual intake and performance trends. When a marker changes, first examine measurement conditions and plausible explanations; food decisions should support adequate supply, tolerance and recovery rather than ending the assessment at one molecular signal or assuming a concentration change automatically establishes a useful intervention.

Muscle contraction can increase GLUT4 trafficking and glucose uptake through partly insulin-independent routes. Circulating insulin may decline during activity while muscle glucose use rises, so lower insulin does not universally imply lower glucose use. Recovery can also change sensitivity. Exercise type, surrounding meals and glucose-lowering medication alter interpretation; physiological changes in healthy exercise should not be transferred directly to medication management or disease without individualized clinical context.

When glucose falls, lower insulin secretion and stronger glucose-supporting signals help preserve availability. Glucagon and catecholamines contribute rapidly, while other hormones act over different time scales. Diabetes, medication and prior hypoglycemia can alter the response. Counter-regulatory does not mean harmful: these signals form part of normal defense. Their interpretation depends on context and exercise intensity rather than assuming every rise reflects a disorder or an unfavorable sports response.

Hormonal imbalance is a broad description rather than a standalone diagnosis from an online symptom list. Deficiency, excess and resistance differ, and reference ranges depend on method, age and conditions. Medicines, illness, sleep and energy status also matter. Persistent symptoms need appropriate assessment to identify causes; choosing supplements or manipulating hormones from one isolated test cannot replace evidence-based evaluation or establish a universal athletic hormone target.